The inhibition of SPHK1 suppresses tumor growth by reversing PD-L1-mediated tumor immune escape and leads to activation of T lymphocytes in immunocompetent mouse models and melanoma cell lines. The gene discussed is SPHK1; the disease is neoplasm.